UBS Moves on Two Fronts as It Retires ETNs and Waits for Q2 Results
Published on 07/17/2026 at 05:52 | Redaktion boerse-global.de
UBS Group AG is keeping its structured-products machine busy even as its shares ease from a fresh high. On 16 July 2026, the bank said it will redeem seven Exchange Traded Notes, with settlement based on the current indicative closing value and a redemption date set for 19 August 2026. Investors will receive cash linked to the valuation date, while UBS said the affected securities and exact payment schedules are disclosed in regulatory filings.
At the same time, the London branch of UBS AG is bringing a new batch of structured debt to market: Digital S&P 500 Index-Linked Medium-Term Notes with maturities of 26 to 29 months. The notes are unsecured, pay no ongoing interest and carry no deposit protection. UBS puts the buffer at 85 percent of the starting index level, with maximum repayment ranging from US$1,167.30 to US$1,196.80 per US$1,000 principal, equal to a cap of 116.73 percent to 119.68 percent. If the S&P 500 falls below the buffer, losses accelerate at a leverage of about 117.65 percent per percentage point, up to a total loss. UBS estimates the initial value of the notes at US$968 to US$998 per US$1,000 principal, below the issue price.
The equity story, meanwhile, has turned choppier after a run to record territory. UBS shares touched a 52-week high of EUR 48.19 in European trading on 14 July, then gave back ground two days later. On Thursday, the stock closed at EUR 46.80 after reaching EUR 46.60 during the session, leaving it 3.00 percent lower on the day and 2.88 percent below the fresh peak. The move came without a specific company trigger. The Swiss market was softer too, with the SMI down 0.3 percent to 14,267 points amid concern over the war in Iran.
Other large Swiss names also weakened. ABB fell sharply after results and the multibillion-franc Rotork acquisition, while Partners Group also lost ground following its half-year figures. UBS, by contrast, has still produced a clear advance over the year: the share price is up 16.42 percent since the start of 2026, and the recent momentum had been solid before the latest pullback.
Should investors sell immediately? Or is it worth buying UBS?
The stock’s rise has been helped by a stream of supportive headlines. Goldman Sachs lifted its price target for UBS on 9 July from 38.50 Swiss francs to 41.50 Swiss francs, while leaving its rating at "Neutral". Reuters also reported that the US Securities and Exchange Commission removed a legal obstacle for crisis scenarios, easing some of the regulatory uncertainty that investors have watched closely since UBS took over Credit Suisse.
That integration remains central to the bank’s day-to-day workload. Bloomberg reported at the end of May that UBS was cutting several hundred jobs across EMEA as part of the merger process, mainly in support functions. The reductions underscore the cost pressure that comes with absorbing Credit Suisse, even as UBS tries to capture the scale benefits of the deal.
The numbers released so far suggest the group is still making progress. In its 2025 annual results, UBS lifted net profit by 53 percent to US$7.8 billion and increased its dividend by 22 percent from the previous year. In the first quarter of 2026, earnings per share rose to CHF 0.77 from CHF 0.48 a year earlier, although revenue fell 9.56 percent on a currency-adjusted basis to CHF 16.21 billion. That points to a business currently leaning more on cost control and efficiency than on top-line growth.
Shareholders backed the board’s proposals at the ordinary general meeting in Basel on 15 April, where capitalisation was one of the key topics. The issue matters more than ever as UBS navigates integration costs and the prospect of tighter or looser rules from regulators in Europe and the United States.
In Brussels, the policy debate is shifting in a way that could matter for the lender. The European Commission plans to publish a report on the competitiveness of the banking sector on 18 July 2026, with proposals extending into 2027. They include scrapping parts of the Pillar 2 capital rules, reducing capital buffers and making cross-border mergers easier. The backdrop is more than a decade of US dominance in global investment banking. Lower capital requirements could ease competition for a bank with UBS’s international reach, though that would not automatically translate into better operating performance.
UBS at a turning point? This analysis reveals what investors need to know now.
The monetary backdrop is also in flux. After unexpectedly weak US inflation data for June, a Federal Reserve rate increase now looks less likely, a view reinforced by comments from New York Fed President John Williams.
Investors now have two dates circled for UBS. The bank will report second-quarter 2026 results on 29 July, followed by third-quarter numbers on 30 October. The latest share-price pause suggests the market is waiting to see whether cost discipline can keep offsetting softer revenue, even as UBS continues to balance buybacks, new issuance and a still-unfinished integration.
Ad
UBS Stock: New Analysis - 17 July
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
